Technology - Organisyl

Why testing anti-aging actives on static 3D skin models limits innovation: The mechanobiology advantage

In the cosmetic and dermocosmetic industries, 3D reconstructed skin models have long replaced traditional animal testing, establishing a gold standard for safety and efficacy evaluations. However, as highlighted in market analyses by consulting firm Alcimed (“Organoids for drug development: 3 strategic considerations for your preclinical pipeline”, 2026), the next frontier for 3D skin models lies

biomimetic 3d cell culture & physioscaffolds

Beyond standard organoids: how Physioscaffolds de-risk preclinical pipelines in the era of FDA NAM guidelines

Technology / gregory.maubon

The global pharmaceutical industry operates under a costly paradox: nearly 95% of drug candidates validated in animal models ultimately fail in human clinical trials. This translation gap drains billions of dollars annually in wasted R&D expenditure and delays life-saving therapeutics from reaching patients. In response, global regulatory authorities are enacting an unprecedented paradigm shift: However,

Beyond standard organoids: how Physioscaffolds de-risk preclinical pipelines in the era of FDA NAM guidelines Read More »